Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McCall

Showing results (491-500 of 501) with videos related to

Pageof 51
Sort By:
BMJ (Clinical Research Ed.)|April 30, 2021
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaborationLinda Kwakkenbos, Mahrukh Imran, Stephen J McCall, et al.
Blood|September 7, 2017
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Heiko Schöder, Somali Gavane, et al.
Prostate Cancer and Prostatic Diseases|October 14, 2021
Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestryBrendon M Patierno, Wen-Chi Foo, Tyler Allen, et al.
NPJ Precision Oncology|January 29, 2025
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrenceMuthana Al Abo, Wen-Chi Foo, Lauren E Howard, et al.
BMJ Open|April 30, 2021
Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)Mahrukh Imran, Linda Kwakkenbos, Stephen J McCall, et al.
Cancer Cell|April 7, 2018
Comparative Molecular Analysis of Gastrointestinal AdenocarcinomasYang Liu, Nilay S Sethi, Toshinori Hinoue, et al.
Nature Communications|May 20, 2022
Automated next-generation profiling of genomic alterations in human cancersLaurel A Keefer, James R White, Derrick E Wood, et al.
Blood|July 27, 2016
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphomaAnita Kumar, Carla Casulo, Joachim Yahalom, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Journal for Immunotherapy of Cancer|January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitorsJeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Pageof 51

Showing results (491-500 of 501) with videos related to

Sort By:
Pageof 51
BMJ (Clinical Research Ed.)|April 30, 2021
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaborationLinda Kwakkenbos, Mahrukh Imran, Stephen J McCall, et al.
Blood|September 7, 2017
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Heiko Schöder, Somali Gavane, et al.
Prostate Cancer and Prostatic Diseases|October 14, 2021
Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestryBrendon M Patierno, Wen-Chi Foo, Tyler Allen, et al.
NPJ Precision Oncology|January 29, 2025
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrenceMuthana Al Abo, Wen-Chi Foo, Lauren E Howard, et al.
BMJ Open|April 30, 2021
Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)Mahrukh Imran, Linda Kwakkenbos, Stephen J McCall, et al.
Cancer Cell|April 7, 2018
Comparative Molecular Analysis of Gastrointestinal AdenocarcinomasYang Liu, Nilay S Sethi, Toshinori Hinoue, et al.
Nature Communications|May 20, 2022
Automated next-generation profiling of genomic alterations in human cancersLaurel A Keefer, James R White, Derrick E Wood, et al.
Blood|July 27, 2016
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphomaAnita Kumar, Carla Casulo, Joachim Yahalom, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Journal for Immunotherapy of Cancer|January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitorsJeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Pageof 51